# ACOSOG Z0011 (NCT00003855)

> Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: invasive breast cancer with sentinel node metastasis

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00003855
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Breast Cancer
- Interventions: axillary lymph node dissection; whole breast irradiation
- Enrollment: 605
- Primary outcome: Overall survival
- Primary outcome: Morbidity
- Primary outcome: Disease-free survival

## Indexed commentary on ACOSOG Z0011 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 9 posts on X
- 4 podcast episodes
- 3 YouTube videos

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=acosog-z0011-nct00003855

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00003855", "email": "<work email>"}; the inbox owner confirms by the emailed link.